The company's purpose is to conduct business in the pharmaceutical, biotechnological and medical technology industries, including the complete or partial conduct of clinical trials, the provision of research services and the transfer of knowledge, particularly in the field of scleroderma. The company may also participate in, found, acquire and merge with other companies of any kind, both domestically and abroad. It may acquire, encumber and dispose of real estate and intellectual property rights, both domestically and abroad, and establish branches and agencies, both domestically and abroad, by resolution of the board of directors. The company may also grant securities and guarantees for the benefit of its shareholders or other group companies and provide loans to its shareholders or other group companies.